CR9846A - 2-amino-7,8-dihidro-6h-pirido[4,3-d]pirimidina-5-onas - Google Patents

2-amino-7,8-dihidro-6h-pirido[4,3-d]pirimidina-5-onas

Info

Publication number
CR9846A
CR9846A CR9846A CR9846A CR9846A CR 9846 A CR9846 A CR 9846A CR 9846 A CR9846 A CR 9846A CR 9846 A CR9846 A CR 9846A CR 9846 A CR9846 A CR 9846A
Authority
CR
Costa Rica
Prior art keywords
amino
pirimidina
pirido
dihidro
onas
Prior art date
Application number
CR9846A
Other languages
English (en)
Spanish (es)
Inventor
Cynthia M Shafer
Brandon M Doughan
Yi Xia
X Michael Wang
Kris Mendenhall
Yasheen Zhou
Baoqing Gong
Dan Gu
John Dolan
John Tulinsky
Kristin Brinner
Daniel Poon
Paul A Barsanti
Lin Xiaodong
Abran Costales
Alice Rico
Nathan Brammeier
Teresa Pick
Paul A Renhowe
Timothy D Machajewski
Christopher Mcbride
William Antonios-Mccrea
Barry H Levine
Maureen Mckenna
Zhenhai Gao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CR9846A publication Critical patent/CR9846A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
CR9846A 2005-09-30 2008-03-28 2-amino-7,8-dihidro-6h-pirido[4,3-d]pirimidina-5-onas CR9846A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72279605P 2005-09-30 2005-09-30
US83688606P 2006-08-09 2006-08-09

Publications (1)

Publication Number Publication Date
CR9846A true CR9846A (es) 2008-08-01

Family

ID=37661234

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9846A CR9846A (es) 2005-09-30 2008-03-28 2-amino-7,8-dihidro-6h-pirido[4,3-d]pirimidina-5-onas

Country Status (31)

Country Link
US (2) US7671059B2 (OSRAM)
EP (1) EP1928875B1 (OSRAM)
JP (2) JP5036002B2 (OSRAM)
KR (1) KR101311757B1 (OSRAM)
AR (1) AR058072A1 (OSRAM)
AT (1) ATE514694T1 (OSRAM)
AU (1) AU2006297124B2 (OSRAM)
BR (1) BRPI0616701A2 (OSRAM)
CA (1) CA2624253C (OSRAM)
CR (1) CR9846A (OSRAM)
CY (1) CY1112028T1 (OSRAM)
DK (1) DK1928875T3 (OSRAM)
EA (1) EA016152B1 (OSRAM)
EC (1) ECSP088324A (OSRAM)
GE (1) GEP20115231B (OSRAM)
HR (1) HRP20110655T1 (OSRAM)
IL (1) IL190446A0 (OSRAM)
JO (1) JO2783B1 (OSRAM)
MA (1) MA29885B1 (OSRAM)
ME (1) ME01952B (OSRAM)
MY (1) MY143604A (OSRAM)
NO (1) NO342258B1 (OSRAM)
NZ (1) NZ566914A (OSRAM)
PE (1) PE20070621A1 (OSRAM)
PL (1) PL1928875T3 (OSRAM)
PT (1) PT1928875E (OSRAM)
RS (1) RS51795B (OSRAM)
SM (1) SMAP200800029A (OSRAM)
TN (1) TNSN08143A1 (OSRAM)
TW (1) TWI373471B (OSRAM)
WO (1) WO2007041362A1 (OSRAM)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2007002994A1 (es) * 2006-10-19 2008-02-08 Wyeth Corp Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros.
CN101225083A (zh) * 2007-01-16 2008-07-23 北京摩力克科技有限公司 四氢喹唑啉酮类化合物及其用于制备治疗和预防病毒性疾病的药物的用途
GB2449293A (en) * 2007-05-17 2008-11-19 Evotec Compounds having Hsp90 inhibitory activity
CN101983191B (zh) * 2008-02-01 2013-11-20 武田药品工业株式会社 作为hsp90抑制剂的肟衍生物
WO2010034670A2 (en) * 2008-09-26 2010-04-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Host cell kinases as targets for antiviral therapies against hcv infection
WO2010060939A2 (en) * 2008-11-28 2010-06-03 Novartis Ag Combination of hsp90 and herceptin inhibitors
US20110230499A1 (en) 2008-11-28 2011-09-22 Novartis Ag Hsp90 inhibitors for therapeutic treatment
CN102227221A (zh) * 2008-11-28 2011-10-26 诺瓦提斯公司 包含hsp90抑制剂和mtor抑制剂的药物组合
AR075180A1 (es) 2009-01-29 2011-03-16 Novartis Ag Formulaciones orales solidas de una pirido-pirimidinona
AR077405A1 (es) 2009-07-10 2011-08-24 Sanofi Aventis Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer
FR2949467B1 (fr) 2009-09-03 2011-11-25 Sanofi Aventis Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation
WO2011053861A1 (en) * 2009-10-29 2011-05-05 Genosco Kinase inhibitors
WO2012104823A2 (en) 2011-02-04 2012-08-09 Novartis Ag Pyridopyrimidinone compounds in the treatment of neurodegenerative diseases
RU2017119219A (ru) 2011-10-14 2018-11-02 Новартис Аг 2-карбоксамид циклоамино производные мочевины в комбинации с ингибиторами hsp90 для лечения пролиферативных заболеваний
ITTO20111013A1 (it) 2011-11-03 2013-05-04 Dac Srl Composti farmaceutici
CN103664938A (zh) * 2012-09-12 2014-03-26 山东亨利医药科技有限责任公司 含有嘧啶并环的syk抑制剂
RU2015121424A (ru) 2012-11-07 2016-12-27 Новартис Аг Комбинированная терапия
US9677907B2 (en) * 2013-03-14 2017-06-13 Itron Inc Intelligent receptacle
GB201306610D0 (en) * 2013-04-11 2013-05-29 Almac Discovery Ltd Pharmaceutical compounds
ES2848706T3 (es) 2013-09-30 2021-08-11 Taiho Pharmaceutical Co Ltd Terapia de combinación contra el cáncer usando un compuesto azabicíclico
MX2017002544A (es) * 2014-09-02 2017-07-19 Pf Medicament Derivados de isoquinolinona utiles en el tratamiento contra el cancer.
KR20160035411A (ko) * 2014-09-23 2016-03-31 주식회사 오스코텍 LRRK2 (Leucine Rich Repeat Kinase 2) 키나제 억제제로서의 피리도피리미딘 유도체 화합물
KR101653560B1 (ko) * 2016-02-02 2016-09-12 한국화학연구원 신규한 화합물 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 함유하는 인플루엔자 바이러스 감염으로 인한 질환의 예방 또는 치료용 약학적 조성물
RU2629599C1 (ru) * 2016-09-28 2017-08-30 Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского" (ГБУЗ МО МОНИКИ им. М.Ф. Владимирского) Способ химиолучевого лечения опухолей прямой кишки и анального канала
JP7229158B2 (ja) 2017-06-09 2023-02-27 中外製薬株式会社 Ｎ－置換アミノ酸を含むペプチドの合成方法
EP4174056A4 (en) * 2020-06-26 2024-08-07 Nihon Nohyaku Co., Ltd. ARYLTETRAHYDROPYRIDINE DERIVATIVE OR SALT THEREOF, INSECTICIDE THEREOF AND METHOD OF USE THEREOF

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6165873A (ja) * 1984-09-07 1986-04-04 Mitsui Petrochem Ind Ltd ２−ピペラジノピリミジン誘導体
US4734418A (en) * 1984-12-14 1988-03-29 Mitsui Petrochemical Industries, Ltd. Quinazoline compounds and antihypertensives
MA21177A1 (fr) 1987-02-11 1988-10-01 May & Baker Ltd Diones cycliques.
CN100376571C (zh) * 2001-02-12 2008-03-26 霍夫曼-拉罗奇有限公司 6-取代的吡啶并嘧啶类化合物
DE102004018198A1 (de) 2004-04-15 2005-11-03 Merck Patent Gmbh Sulfonamide
EP2332527A3 (en) 2004-10-20 2011-11-16 Resverlogix Corp. Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases
WO2006074293A2 (en) * 2005-01-07 2006-07-13 President And Fellows Of Harvard College Bicyclic dihydropyrimidines as eg5 inhibitors
AU2006236557A1 (en) * 2005-04-14 2006-10-26 Novartis Vaccines And Diagnostics Inc. 2-amino-quinazolin-5-ones as HSP90 inhibitors useful in treating proliferation diseases

Also Published As

Publication number Publication date
CA2624253A1 (en) 2007-04-12
CY1112028T1 (el) 2015-11-04
US20070123546A1 (en) 2007-05-31
ME01952B (en) 2011-12-31
PL1928875T3 (pl) 2011-11-30
KR20080057318A (ko) 2008-06-24
EP1928875B1 (en) 2011-06-29
TNSN08143A1 (en) 2009-07-14
JP5036002B2 (ja) 2012-09-26
CA2624253C (en) 2015-06-16
MA29885B1 (fr) 2008-10-03
ECSP088324A (es) 2008-04-28
NO342258B1 (no) 2018-04-30
US20100004237A1 (en) 2010-01-07
AU2006297124B2 (en) 2011-12-08
TW200728304A (en) 2007-08-01
SMP200800029B (it) 2008-05-07
US7671059B2 (en) 2010-03-02
JO2783B1 (en) 2014-03-15
NO20082069L (no) 2008-06-09
IL190446A0 (en) 2008-11-03
HRP20110655T1 (hr) 2011-10-31
EA016152B1 (ru) 2012-02-28
AR058072A1 (es) 2008-01-23
GEP20115231B (en) 2011-06-10
EP1928875A1 (en) 2008-06-11
WO2007041362A1 (en) 2007-04-12
DK1928875T3 (da) 2011-10-03
MY143604A (en) 2011-06-15
NZ566914A (en) 2011-09-30
JP2012158611A (ja) 2012-08-23
PT1928875E (pt) 2011-09-06
AU2006297124A1 (en) 2007-04-12
RS51795B (sr) 2011-12-31
BRPI0616701A2 (pt) 2011-06-28
SMAP200800029A (it) 2008-05-07
KR101311757B1 (ko) 2013-09-26
ATE514694T1 (de) 2011-07-15
PE20070621A1 (es) 2007-09-06
JP2009510108A (ja) 2009-03-12
TWI373471B (en) 2012-10-01
EA200800992A1 (ru) 2008-10-30
HK1118823A1 (en) 2009-02-20

Similar Documents

Publication Publication Date Title
CR9846A (es) 2-amino-7,8-dihidro-6h-pirido[4,3-d]pirimidina-5-onas
SV2008003074A (es) Piridin[3,4-b] pirazinonas
SG162804A1 (en) Pyrazole based lxr modulators
MX2009003038A (es) Derivados de quinazolinona 5-sustituidos como agentes antitumorales.
GT200900283A (es) "terapia de combinación con un compuesto actuando como un inhibidor del receptor adp plaquetario".
MY157495A (en) 6-,7-, or 8-substituted quinazolinone derivatives and compositions comprising and methods of using the same
TW200745078A (en) Isoindole-imide compounds and compositions comprising and methods of using the same
ATE302775T1 (de) Carbolinderivate
CR11036A (es) Derivados y composiciones de isoindol 4' -o- sustituidos, composiciones que las comprenden y metodos de uso de los mismos
EP1545545A4 (en) COMPOUNDS WITH THE BICYCLO 4.2.1 NONAN SYSTEM FOR THE TREATMENT OF FLAVIVIRIDAE / I INFECTIONS
UY27729A1 (es) Inhibidores de quinasas.
UY29246A1 (es) Nuevos compuestos
UY27350A1 (es) Azaindoles
ATE430747T1 (de) 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren
MX2010006107A (es) Derivados de espiroindolinona.
IS7453A (is) Trópan afleiður sem CCR5 stillar
SV2008002856A (es) 2-amino-7, 8-dihidro-6h-pirido [4,3-d] pirimidina-5-onas
IL175992A0 (en) Substituted arylpyrazoles as parasiticidal agents
CL2009000281A1 (es) Compuestos derivados de 5,6-dihidro-pirrolo-[2,1-a]-isoquinolinas y pirrolo-[2,1-a]-isoquinolinas; composicion farmaceutica que comprende a dichos compuestos; y uso para el tratamaiento de trastornos de la fertilidad.
ATE346067T1 (de) Carbolinderivate
JO2578B1 (en) Compounds Theophene benzimidazole
UY27685A1 (es) Indolil-urea derivados de tienopiridinas útiles como agentes antiangiogénicos, y procedimientos para su uso
ATE438398T1 (de) Pyrrolo-dihydroisochinolin-derivate als pde10- inhibitoren
SE0301650D0 (sv) Novel compounds
WO2007120333A3 (en) Tetracyclic kinase inhibitors